Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Older men with late-onset lupus have a higher mortality rate than women.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Hair loss doesn't affect COVID-19 severity.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

There might be a skin condition related to COVID-19.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.